Clinical Trials on Locally Advanced or Metastatic Castration-resistant Prostate Cancer
Total 1113 results
-
Merck Sharp & Dohme LLCCompletedMetastatic or Locally Advanced Cancer
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityAstraZenecaRecruitingProstate Cancer | Prostate Carcinoma | Metastatic Castration-resistant Prostate CancerChina
-
Peking Union Medical College HospitalNational Institute for Biomedical Imaging and Bioengineering (NIBIB)RecruitingMetastatic Castration-resistant Prostate CancerChina
-
Allife Medical Science and Technology Co., Ltd.Tianjin People's HospitalRecruitingMetastatic Castration-resistant Prostate CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingMetastatic Castration Resistant Prostate CancerChina
-
Dizal PharmaceuticalsTerminatedMetastatic Castration Resistant Prostate CancerUnited States, Korea, Republic of
-
Janssen-Cilag Farmaceutica Ltda.CompletedMetastatic Castration-resistant Prostate CancerBrazil
-
SOTIO a.s.CompletedMetastatic Castration-resistant Prostate CancerUnited States, Spain, United Kingdom, Germany, Serbia, Portugal, Lithuania, Slovakia, Hungary, Netherlands, Croatia, France, Czechia, Poland, Austria, Belarus, Belgium, Bulgaria, Denmark, Italy, Latvia, Sweden
-
Sidney Kimmel Comprehensive Cancer Center at Johns...United States Department of DefenseCompletedCastration Resistant Metastatic Prostate CancerUnited States
-
Hinova Pharmaceuticals Inc.West China HospitalCompletedMetastatic Castration Resistant Prostate CancerChina
-
British Columbia Cancer AgencyCompletedMetastatic Castration-Resistant Prostate CancerCanada
-
MedImmune LLCCompletedMetastatic Castration Resistant Prostate CancerUnited States, Switzerland, United Kingdom
-
Nanjing First Hospital, Nanjing Medical UniversityUnknownMetastatic Castration-resistant Prostate CancerChina
-
Astellas Pharma a/sCompletedMetastatic Castration Resistant Prostate CancerSweden
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedMetastatic Castration Resistant Prostate CancerChina
-
Astellas Pharma Europe Ltd.Medivation, Inc.CompletedMetastatic Castration Resistant Prostate CancerCzechia, Netherlands, Denmark, Italy, Austria, Belgium, Bulgaria, France, Germany, Greece, Hungary, Ireland, Portugal, Slovenia, Spain, United Kingdom
-
University of Alabama at BirminghamAmgenCompletedPhase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following TreatmentMetastatic Castration-resistant Prostate CancerUnited States
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedMetastatic Castration-Resistant Prostate CancerBelgium, France, Germany, Spain, United Kingdom
-
Astellas Pharma Global Development, Inc.Medivation, Inc.TerminatedMetastatic Castration Resistant Prostate CancerUnited States
-
Peking Union Medical College HospitalNational Institute for Biomedical Imaging and Bioengineering (NIBIB)UnknownMetastatic Castration-resistant Prostate CancerChina
-
Rahul AggarwalSanofiCompletedMetastatic Castration-resistant Prostate CancerUnited States
-
Cellular Biomedicine Group Ltd.Fudan UniversityUnknownMetastatic Castration-resistant Prostate CancerChina
-
Jeffrey Yachnin M.D., PhD.SanofiCompletedMetastatic Castration Resistant Prostate CancerSweden
-
Astellas Pharma Global Development, Inc.Medivation, Inc.WithdrawnMetastatic Castration-Resistant Prostate Cancer
-
Celcuity IncRecruitingProstate Cancer | Prostatic Neoplasms, Castration-Resistant | Genital Diseases, Male | Prostatic Disease | mCRPC (Metastatic Castration-resistant Prostate Cancer) | Urogenital Diseases, MaleUnited States, France, Spain, United Kingdom
-
Shanghai Humantech Biotechnology Co. LtdShanghai Changhai Hospital,The First Affiliated Hospital of Naval Medical...RecruitingMetastatic Castration-resistant Prostate CancerChina
-
FutureChemCompletedMetastatic Castration-resistant Prostate CancerKorea, Republic of
-
Hinova Pharmaceuticals Inc.CompletedMetastatic Castration Resistant Prostate CancerChina
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.CompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
Astellas Pharma Global Development, Inc.Medivation, Inc.Approved for marketingMetastatic Castration-Resistant Prostate Cancer
-
Translational Research Center for Medical Innovation...CompletedCastration Resistant Prostate Cancer (CRPC)
-
Rigshospitalet, DenmarkCompletedCastration-resistant Prostate CancerDenmark
-
University Health Network, TorontoCompletedCastration-resistant Prostate CancerCanada
-
Merus N.V.RecruitingMetastatic Castration-resistant Prostate Cancer | NSCLC Harboring NRG1 FusionUnited States
-
BayerOrion Corporation, Orion PharmaCompletedProstate Cancer Non-Metastatic | Castration-ResistantBelgium, France, Poland, Spain, Canada, United States, Estonia, Portugal, Taiwan, Japan, Russian Federation, Finland, Germany, Austria, Czechia, Hungary, Australia, Brazil, South Africa, Latvia, Italy, United Kingdom, Turkey, Serbia, Ro... and more
-
BayerCompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)United States
-
Centro Nacional de Investigaciones Oncologicas...Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina...UnknownAdvanced Prostate Cancer | Castration Resistant | EnzalutamideSpain
-
AstraZenecaCompletedLocally Advanced or Metastatic Prostate Cancer.Greece
-
BayerCompletedMetastatic Castration Resistant Prostate Cancer (mCRPC)United States
-
Jiangsu HengRui Medicine Co., Ltd.CompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)China
-
Memorial Sloan Kettering Cancer CenterProgenics Pharmaceuticals, Inc.CompletedProstate Cancer | Metastatic Castration-Resistant Prostate Cancer (mCRPC)United States
-
Tiltan Pharma Ltd.UnknownMetastatic Castration Resistant Prostate Cancer (CRPC)Israel
-
National Cancer Institute, NaplesActive, not recruitingMetastatic Castration-resistent Prostate CancerItaly
-
University of California, San FranciscoMerck Sharp & Dohme LLC; Prostate Cancer FoundationRecruitingProstate Cancer | Prostate Carcinoma | Metastatic Castration-resistant Prostate Cancer | Castrate Resistant Prostate CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)Korea, Republic of, United States, Spain, France, Belgium, China, Taiwan, United Kingdom, Australia, Czechia, Hungary, Poland, Russian Federation
-
Athenex, Inc.CompletedBone-Metastatic, Castration-Resistant Prostate CancerUnited States
-
Constellation PharmaceuticalsActive, not recruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)United States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Progressive Castration-resistant Prostate CancerUnited States
-
Duke UniversityBayerCompletedPharmacodynamic Study of Radium-223 in Men With Bone Metastatic Castration-Resistant Prostate CancerBone Metastatic Castration-Resistant Prostate CancerUnited States